Related Experiment Video
Updated: May 17, 2025
07:18
Investigating Intestinal Barrier Breakdown in Living Organoids
Published on: March 26, 2020
10.9K
Intestinal barrier damage caused by addictive substance use disorder.
Yan Gao1, Deshenyue Kong1,2, Jia-Xue Sun1,2
1Yunnan Technological Innovation Centre of Drug Addiction Medicine, Yunnan University, Kunming, 650504, China.
European Journal of Medical Research
|April 2, 2025
Summary
Addictive substance use disorder damages the intestinal barrier, impacting the gut-brain axis and potentially worsening addiction. Targeting gut health may help alleviate withdrawal symptoms and dependence.
Area of Science:
- Neuroscience
- Gastroenterology
- Addiction Research
Background:
- Addictive substance use disorder (ASUD) significantly impacts the intestinal barrier.
- Damage to biological, chemical, mechanical, and immune intestinal barriers allows systemic inflammation and immune dysregulation.
Purpose of the Study:
- To review the effects of ASUD on the intestinal barrier.
- To explore therapeutic strategies targeting gut barrier damage for addiction treatment.
Main Methods:
- Review of existing literature on ASUD, intestinal barrier function, and the gut-brain axis.
- Analysis of the mechanisms linking gut dysbiosis to neurological and behavioral changes in addiction.
Main Results:
- ASUD-induced gut barrier damage facilitates translocation of harmful substances, triggering systemic inflammation.
- Gut barrier dysfunction contributes to dysbiosis, affecting the gut-brain axis and exacerbating addiction-related symptoms.
- Altered gut microbiota composition is linked to mood changes, cognitive deficits, and increased cravings.
Conclusions:
- Reshaping the gut-brain axis and modulating gut microbiota show potential for managing ASUD.
- Treating intestinal barrier damage may offer a novel therapeutic avenue for addiction dependence and withdrawal symptoms.
More Related Videos
Related Concept Videos
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
154
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
154
01:17Chronic Bowel Disorders: Introduction
363
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
363
01:17Drugs for Treatment of Diarrhea-Predominant IBS
126
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
126
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
375
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
375
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
137
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
137
01:24Substance Use Disorders Affecting Sleep
151
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
151